Picture of GSK logo

GSK GSK News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

REG - GSK PLC - Total Voting Rights

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230601:nRSA2096Ba&default-theme=true

RNS Number : 2096B  GSK PLC  01 June 2023

GSK plc

 Total Voting Rights and Capital

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and
Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market
of the following:

 

The Company's issued share capital as at 31 May 2023 consisted of
4,312,058,959 shares of 31 ¼ pence each ('Ordinary Shares'), of which
217,068,169 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,094,990,790.
 This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the Financial
Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Notifications may be sent to company.secretary@gsk.com
(mailto:company.secretary@gsk.com) .

 

 

V A Whyte

Company Secretary

1 June 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRBXGDULBXDGXB

Recent news on GSK

See all news